ESR1 and breast cancer: The breast cancer model is uniquely advantageous because it already has established modifiable risk factors, such as menopausal hormone therapy, options for chemoprevention (e.g., endocrine therapy prevents estrogen receptor positive breast cancer), and screening strategies for early detection.